Aclarubicin Other names: Aclacinomycin A

Chemical formula: C₄₂H₅₃NO₁₅  Molecular mass: 811.878 g/mol  PubChem compound: 451415

Therapeutic indications

Aclarubicin is indicated for:

Acute leukemias

at least one of
Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Acute promyelocytic leukaemia
Acute monocytic leukaemia
Acute megakaryoblastic leukaemia
Acute leukaemia of unspecified cell type

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Aclarubicin is contraindicated in the following cases:

Pre-existing heart disorder

at least one of
Chronic rheumatic heart diseases
Ischaemic heart diseases
Other forms of heart disease

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.